AnuBio
Plug and Play · Reprogramming immunomodulation using AI to cure cancer
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCS21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW23 | |
| Other | Public | YCW15 | |
| AI | Active | YCW15 | |
| AI | Active | YCW26 | |
| AI | Active | YCS15 |
Also from Plug and Play in AI
All of Plug and PlayPrograms
| Program | Cohort | Source |
|---|---|---|
| Not stated | Plug and Play Page |
About AnuBio
"AnuBio is a pioneering company in the fields of Artificial Intelligence, Deeptech, and Health, dedicated to reprogramming immunomodulation for cancer treatment. Utilizing phenotypic drug discovery of combinatorial biologics, AnuBio has developed a pair of groundbreaking technologies that enhance the discovery of novel immunomodulators by 100-fold. These technologies include PHENOMS, a proprietary in vitro phenotypic screening platform combined with multispecific biologics, and TRAILBLAZER AI, a revolutionary architecture AI model of the immune system. By synergizing these technologies, AnuBio has created a closed-loop lab-AI research platform that integrates real-world data and validation from PHENOMS with predictive insights from TRAILBLAZER AI. This innovative approach streamlines the drug discovery process, offering valuable predictions for success at every stage."
- Category
- AI
- Location
- United States
- Checked
- 3h ago
AnuBio: questions
Which accelerators did AnuBio go through?
AnuBio is listed by Plug and Play.
Where is AnuBio based?
AnuBio lists United States as its location on Plug and Play's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.